AIM ImmunoTech issues 1,921,441 shares in $450,000 debt exchange with Streeterville Capital
AIM•Unregistered issuance
The shares were issued or will be issued in an unregistered transaction under Securities Act Section 3(a)(9).
Debt exchange with Streeterville Capital
AIM ImmunoTech entered two exchange agreements with Streeterville Capital on Sept. 3-4, 2026, converting about $450,000 of a promissory note.
The conversion issued 1,921,441 common shares at an average price of about $0.23 per share.
